AJP - Renal Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 293: F186-F192, 2007. First published March 27, 2007; doi:10.1152/ajprenal.00484.2006
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/F186    most recent
00484.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Usa, K.
Right arrow Articles by Liang, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Usa, K.
Right arrow Articles by Liang, M.

Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats

Kristie Usa,1 Ravinder J. Singh,2 Brian C. Netzel,2 Yong Liu,1 Hershel Raff,3,4 and Mingyu Liang1

1Department of Physiology, Medical College of Wisconsin, Milwaukee; 2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 3Department of Medicine, Medical College of Wisconsin, Milwaukee; and 4Endocrine Research Laboratory, Aurora St. Luke's Medical Center, Milwaukee, Wisconsin

Submitted 7 December 2006 ; accepted in final form 23 March 2007

Deficiencies in the conversion between active and inactive glucocorticoids in the kidney can lead to hypertension. However, the significance of glucocorticoid metabolism in specific kidney regions in vivo is not clear, possibly in part due to the difficulty in measuring glucocorticoid levels in kidney regions in vivo. We used microdialysis techniques to sample renal interstitial fluid from conscious rats. The levels of corticosterone (active) and 11-dehydrocorticosterone (inactive) were analyzed by liquid chromatography-tandem mass spectrometry. Direct infusion of the 11beta-hydroxysteroid dehydrogenase (11beta-HSD) inhibitor carbenoxolone into the renal medulla induced hypertension, and significantly increased corticosterone levels and the corticosterone/11-dehydrocorticosterone ratio, an index of 11beta-HSD activity, in the renal medullary microdialysate, but not in urine or the plasma. Further characterization of conscious, untreated rats (n = 13–16) indicated that corticosterone concentrations (ng/ml) were 0.8 ± 0.1, 1.0 ± 0.1, 66.7 ± 8.1, and 7.9 ± 1.1 in cortical microdialysate, medullary microdialysate, the plasma, and urine, respectively. The corticosterone/11-dehydrocorticosterone ratios were 0.8 ± 0.1, 0.6 ± 0.1, 10.6 ± 1.4, and 1.7 ± 0.1, respectively, in these 4 types of sample. The expression level of 11beta-HSD1 was higher in the medulla than in the cortex, whereas 11beta-HSD2 was most enriched in the outer medulla. Microdialysate levels of corticosterone were ~1.6-fold higher in afternoons than in mornings, whereas plasma levels differed by 2.8-fold. These results demonstrated that corticosterone excess in the renal medulla might be sufficient to cause hypertension and provided the first characterization of renal interstitial glucocorticoids.

hypertension; 11beta-hydroxysteroid dehydrogenase; microdialysis; mass spectrometry



Address for reprint requests and other correspondence: M. Liang, Dept. of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226 (e-mail: mliang{at}mcw.edu)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Y. Liu, D. Mladinov, J. L. Pietrusz, K. Usa, and M. Liang
Glucocorticoid response elements and 11{beta}-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression
Cardiovasc Res, January 1, 2009; 81(1): 140 - 147.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
Y. Liu, R. J. Singh, K. Usa, B. C. Netzel, and M. Liang
Renal medullary 11{beta}-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension
Physiol Genomics, December 12, 2008; 36(1): 52 - 58.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. Liang, N. H. Lee, H. Wang, A. S. Greene, A. E. Kwitek, M. L. Kaldunski, T. V. Luu, B. C. Frank, S. Bugenhagen, H. J. Jacob, et al.
Molecular networks in Dahl salt-sensitive hypertension based on transcriptome analysis of a panel of consomic rats
Physiol Genomics, June 1, 2008; 34(1): 54 - 64.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Tian, A. S. Greene, K. Usa, I. R. Matus, J. Bauwens, J. L. Pietrusz, A. W. Cowley Jr, and M. Liang
Renal Regional Proteomes in Young Dahl Salt-Sensitive Rats
Hypertension, April 1, 2008; 51(4): 899 - 904.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
Y. Liu, F. Park, J. L. Pietrusz, G. Jia, R. J. Singh, B. C. Netzel, and M. Liang
Suppression of 11{beta}-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis
Physiol Genomics, February 19, 2008; 32(3): 343 - 351.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.